Sign Up
Stories
Weight Loss Drugs: Benefits and Risks
Share
ANJESO Drug Insight and Market Forecast
Amgen's Obesity Prospects and Q4 Results...
Anti-Obesity Meds' Impact on Allurion Pr...
Overview
API
The European Medicines Agency (EMA) and the American Diabetes Association (ADA) have stated that there is no evidence to link weight loss drugs like Ozempic and Wegovy to thyroid cancer or stomach issues. However, GLP-1 drugs have shown benefits beyond weight loss, including heart, liver, and kidney protection, substance abuse combat, and potential treatments for Alzheimer's and Parkinson's diseases.
Ask a question
How might the benefits and risks of GLP-1 drugs influence the development and regulation of future weight loss and diabetes medications?
How might the lack of evidence linking weight loss drugs to thyroid cancer and stomach issues impact public perception and trust in these medications?
What steps can regulatory authorities take to ensure the safety and efficacy of GLP-1 drugs while addressing potential side effects and health concerns?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Apr 2023
Jun 2023
Aug 2023
Oct 2023
Coverage